Unknown

Dataset Information

0

Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer.


ABSTRACT: Despite continued widespread use, the genomic effects of cisplatin-based chemotherapy and implications for subsequent treatment are incompletely characterized. Here, we analyze whole exome sequencing of matched pre- and post-neoadjuvant cisplatin-based chemotherapy primary bladder tumor samples from 30 muscle-invasive bladder cancer patients. We observe no overall increase in tumor mutational burden post-chemotherapy, though a significant proportion of subclonal mutations are unique to the matched pre- or post-treatment tumor, suggesting chemotherapy-induced and/or spatial heterogeneity. We subsequently identify and validate a novel mutational signature in post-treatment tumors consistent with known characteristics of cisplatin damage and repair. We find that post-treatment tumor heterogeneity predicts worse overall survival, and further observe alterations in cell-cycle and immune checkpoint regulation genes in post-treatment tumors. These results provide insight into the clinical and genomic dynamics of tumor evolution with cisplatin-based chemotherapy, suggest mechanisms of clinical resistance, and inform development of clinically relevant biomarkers and trials of combination therapies.

SUBMITTER: Liu D 

PROVIDER: S-EPMC5736752 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature

Similar Datasets

2020-03-26 | GSE145140 | GEO
2020-03-26 | GSE145139 | GEO
2020-03-26 | GSE145137 | GEO
| S-EPMC8362849 | biostudies-literature
| PRJNA606179 | ENA
| S-EPMC9277948 | biostudies-literature
| S-EPMC6797575 | biostudies-literature
| S-EPMC8376795 | biostudies-literature
| S-EPMC6511250 | biostudies-literature
| EGAS00001004231 | EGA